J
Josef Jampilek
Researcher at Comenius University in Bratislava
Publications - 331
Citations - 6091
Josef Jampilek is an academic researcher from Comenius University in Bratislava. The author has contributed to research in topics: Lipophilicity & Chemistry. The author has an hindex of 36, co-authored 303 publications receiving 4695 citations. Previous affiliations of Josef Jampilek include Palacký University, Olomouc & Slovak Academy of Sciences.
Papers
More filters
Journal ArticleDOI
X-ray and Thermal Analysis of Selected Drugs Containing Acetaminophen.
TL;DR: Results obtained by a combination of the two methods, X-ray powder diffraction (XRPD) and differential scanning calorimetry/thermogravimetry (DSC/TGA) may be useful in determination of abnormalities which can occur in pharmaceutical preparations, e.g., for distinguishing original drugs and forged products.
Patent
Dosage forms of tyrosine kinase inhibitors
TL;DR: Co-crystals of inhibitors of tyrosine kinases, especially of Imatinib mesylate, have been found as a suitable form of API for dosage forms, both conventional and with controlled release for medicaments of the second generation as discussed by the authors.
Journal ArticleDOI
Proline-Based Carbamates as Cholinesterase Inhibitors.
Hana Pizova,Havelkova M,Sarka Stepankova,Andrzej Bak,Tereza Kauerova,Kozik,Michal Oravec,Ales Imramovsky,Peter Kollar,Pavel Bobal,Josef Jampilek +10 more
TL;DR: The comprehensive screening of the AChE/BChE profile revealed potentially relevant structural and physicochemical features that might be essential for mapping of the carbamates inhibition efficiency indicating qualitative variations exerted on the reaction site by the substituent in the 3′-/4′-position of the phenyl ring.
Journal ArticleDOI
Transdermal Application of Drugs and Techniques Affecting Skin Barrier
TL;DR: The development in the field of pharmaceutical dosage forms results in discovery of additional highly sophisticated drug delivery systems that allow maintaining constant level of active substance in organism.
Journal ArticleDOI
Antimycobacterial N-alkoxyphenylhydroxynaphthalenecarboxamides affecting photosystem II.
TL;DR: The section between P680 and plastoquinone QB in the PET chain occurring on the acceptor side of PSII can be suggested as the site of action of the compounds.